Literature DB >> 27647792

Risk Factors for Cognitive Impairment in Fragile X-Associated Tremor/Ataxia Syndrome.

Andreea L Seritan1, Kyoungmi Kim2,3, Ian Benjamin4, Ioana Seritan5, Randi J Hagerman3,6.   

Abstract

Fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disease with motor, psychiatric, and cognitive manifestations that occurs in carriers of the fragile X mental retardation 1 ( FMR1) gene premutations. This was a retrospective chart review of 196 individuals (127 men and 69 women) with FXTAS. Forty-six (23%) participants were cognitively impaired, of whom 19 (10%) had dementia. Risk factors for dementia were examined (CGG repeat size; alcohol, benzodiazepine, and opioid use; diabetes; hyperlipidemia; hypertension; hypothyroidism; obesity; sleep apnea; surgeries with general anesthesia; depression; family history of dementia). Thirteen individuals with FXTAS and dementia were then compared to 13 cognitively intact individuals matched on age, gender, and FXTAS stage. CGG repeat size was significantly higher (mean = 98.5, standard deviation [SD] = 22.2) in the dementia group, compared to the cognitively intact group (mean = 81.6, SD = 11.5; P = .0256). These results show that CGG repeat size is a risk factor for FXTAS dementia.

Entities:  

Keywords:  FMR1 premutation; FXTAS; cognitive impairment; dementia

Year:  2016        PMID: 27647792      PMCID: PMC5357600          DOI: 10.1177/0891988716666379

Source DB:  PubMed          Journal:  J Geriatr Psychiatry Neurol        ISSN: 0891-9887            Impact factor:   2.680


  64 in total

Review 1.  Very early detection of Alzheimer neuropathology and the role of brain reserve in modifying its clinical expression.

Authors:  James A Mortimer; Amy R Borenstein; Karen M Gosche; David A Snowdon
Journal:  J Geriatr Psychiatry Neurol       Date:  2005-12       Impact factor: 2.680

2.  Symptomatic treatment in the fragile X-associated tremor/ataxia syndrome.

Authors:  Deborah A Hall; Elizabeth Berry-Kravis; Randi J Hagerman; Paul J Hagerman; Cathlin D Rice; Maureen A Leehey
Journal:  Mov Disord       Date:  2006-10       Impact factor: 10.338

3.  Atypical clinical course of FXTAS: rapidly progressive dementia as the major symptom.

Authors:  M R R Gonçalves; L P Capelli; R Nitrini; E R Barbosa; C S Porto; L T Lucato; A M Vianna-Morgante
Journal:  Neurology       Date:  2007-05-22       Impact factor: 9.910

4.  COGNITIVE DYSFUNCTION IN FMR1 PREMUTATION CARRIERS.

Authors:  Andreea Seritan; Jennifer Cogswell; Jim Grigsby
Journal:  Curr Psychiatry Rev       Date:  2013-02

5.  Hypertension in FMR1 premutation males with and without fragile X-associated tremor/ataxia syndrome (FXTAS).

Authors:  Alyssa A Hamlin; Dina Sukharev; Luis Campos; Yi Mu; Flora Tassone; David Hessl; Danh V Nguyen; Danuta Loesch; Randi J Hagerman
Journal:  Am J Med Genet A       Date:  2012-04-23       Impact factor: 2.802

6.  Impact of the Fragile X mental retardation 1 (FMR1) gene premutation on neuropsychiatric functioning in adult males without fragile X-associated Tremor/Ataxia syndrome: a controlled study.

Authors:  Cary S Kogan; Jeremy Turk; Randi J Hagerman; Kim M Cornish
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2008-09-05       Impact factor: 3.568

7.  Lifespan changes in working memory in fragile X premutation males.

Authors:  Kim M Cornish; Cary S Kogan; Lexin Li; Jeremy Turk; Sebastien Jacquemont; Randi J Hagerman
Journal:  Brain Cogn       Date:  2008-12-27       Impact factor: 2.310

8.  Fragile X-associated tremor/ataxia syndrome: influence of the FMR1 gene on motor fiber tracts in males with normal and premutation alleles.

Authors:  Jun Yi Wang; David Hessl; Andrea Schneider; Flora Tassone; Randi J Hagerman; Susan M Rivera
Journal:  JAMA Neurol       Date:  2013-08       Impact factor: 18.302

9.  High apolipoprotein E4 allele frequency in FXTAS patients.

Authors:  Francisca Silva; Laia Rodriguez-Revenga; Irene Madrigal; Maria Isabel Alvarez-Mora; Rafael Oliva; Montserrat Milà
Journal:  Genet Med       Date:  2013-03-14       Impact factor: 8.822

Review 10.  Treatment of fragile X-associated tremor ataxia syndrome (FXTAS) and related neurological problems.

Authors:  Randi J Hagerman; Deborah A Hall; Sarah Coffey; Maureen Leehey; James Bourgeois; John Gould; Lin Zhang; Andreea Seritan; Elizabeth Berry-Kravis; John Olichney; Joshua W Miller; Amy L Fong; Randall Carpenter; Cathy Bodine; Louise W Gane; Edgar Rainin; Hillary Hagerman; Paul J Hagerman
Journal:  Clin Interv Aging       Date:  2008       Impact factor: 4.458

View more
  9 in total

Review 1.  [Fragile X associated tremor/ataxia syndrome: its clinical presentation, pathology, and treatment].

Authors:  M J Salcedo-Arellano; R J Hagerman; V Martinez-Cerdeno
Journal:  Rev Neurol       Date:  2019-03-01       Impact factor: 0.870

Review 2.  Fragile X-Associated Diminished Ovarian Reserve and Primary Ovarian Insufficiency from Molecular Mechanisms to Clinical Manifestations.

Authors:  Limor Man; Jovana Lekovich; Zev Rosenwaks; Jeannine Gerhardt
Journal:  Front Mol Neurosci       Date:  2017-09-12       Impact factor: 5.639

3.  Open-label pilot clinical trial of citicoline for fragile X-associated tremor/ataxia syndrome (FXTAS).

Authors:  Deborah A Hall; Erin E Robertson; Maureen Leehey; Andrew McAsey; Bichun Ouyang; Elizabeth Berry-Kravis; Joan A O'Keefe
Journal:  PLoS One       Date:  2020-02-13       Impact factor: 3.240

Review 4.  Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS): Pathophysiology and Clinical Implications.

Authors:  Ana Maria Cabal-Herrera; Nattaporn Tassanakijpanich; Maria Jimena Salcedo-Arellano; Randi J Hagerman
Journal:  Int J Mol Sci       Date:  2020-06-20       Impact factor: 5.923

Review 5.  Fragile X Premutation: Medications, Therapy and Lifestyle Advice.

Authors:  Deepika Kour Sodhi; Randi Hagerman
Journal:  Pharmgenomics Pers Med       Date:  2021-12-29

6.  Case Report: Coexistence of Alzheimer-Type Neuropathology in Fragile X-Associated Tremor Ataxia Syndrome.

Authors:  Maria Jimena Salcedo-Arellano; Desiree Sanchez; Jun Yi Wang; Yingratana A McLennan; Courtney Jessica Clark; Pablo Juarez; Andrea Schneider; Flora Tassone; Randi J Hagerman; Verónica Martínez-Cerdeño
Journal:  Front Neurosci       Date:  2021-09-17       Impact factor: 4.677

Review 7.  Cognitive Dysfunction in Repeat Expansion Diseases: A Review.

Authors:  Sizhe Zhang; Lu Shen; Bin Jiao
Journal:  Front Aging Neurosci       Date:  2022-04-11       Impact factor: 5.750

8.  Parkinsonism Versus Concomitant Parkinson's Disease in Fragile X-Associated Tremor/Ataxia Syndrome.

Authors:  María Jimena Salcedo-Arellano; Marisol Wendy Wolf-Ochoa; Tiffany Hong; Sarwat Amina; Flora Tassone; Mirna Lechpammer; Randi Hagerman; Verónica Martínez-Cerdeño
Journal:  Mov Disord Clin Pract       Date:  2020-04-09

9.  Characterization of the Cerebrospinal Fluid Proteome in Patients with Fragile X-Associated Tremor/Ataxia Syndrome.

Authors:  Diana A Abbasi; Thu T A Nguyen; Deborah A Hall; Erin Robertson-Dick; Elizabeth Berry-Kravis; Stephanie M Cologna
Journal:  Cerebellum       Date:  2021-05-27       Impact factor: 3.847

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.